A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.
about
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?Childhood immune thrombocytopenia: Clinical presentation and managementChildhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic PurpuraIdiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraChronic idiopathic thrombocytopenic purpura in children: case reports of spontaneous recovery without splenectomy.Acute immune thrombocytopenic purpura in infants: associated factors, clinical features, treatment and long-term outcome.Recurrent immune thrombocytopenic purpura in children.Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease.Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpuraIdiopathic thrombocytopenic purpura in childhood: a 10-year audit.Response to mercaptopurine for refractory autoimmune cytopenias in children.One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopeniaNovel clearance mechanisms of platelets.Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).Chickenpox-associated immune thrombocytopenic purpura.Use of romiplostim for primary immune thrombocytopenia in children.Rituximab for children with immune thrombocytopenia: a systematic review.Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools.Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.Update on the Intercontinental Cooperative ITP Study Group (ICIS) and on the Pediatric and Adult Registry on Chronic ITP (PARC ITP).Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.Newly diagnosed immune thrombocytopenia: update on diagnosis and management.Clinical practice: immune thrombocytopenia in paediatrics.A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding.Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience.Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRANIschemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report.Comparative of three methods (ELIZA, MAIPA and flow cytometry) to determine anti-platelet antibody in children with ITP.High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.Increased susceptibility to infections before the diagnosis of immune thrombocytopenia.Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines.Hospitalizations in pediatric patients with immune thrombocytopenia in the United States.Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old.Factors associated with the effect of open splenectomy for immune thrombocytopenic purpura.
P2860
Q24674173-B24DA85B-92BC-453F-82CE-F599700CDBB5Q27023294-C2BCB156-0AFB-45F7-B6A6-69B3C3D979D4Q30808680-9D5B2A4E-F6B3-47B0-801E-6C3D51529363Q33363313-11D3F691-6D96-4299-8072-EA56B4F3955FQ33364664-B52124F3-23F0-4C36-B9FB-AA966EC08518Q33369574-4D3E9130-C5C2-49B2-981B-E427EA77EE66Q33371982-90D29D45-95D0-4A36-8D02-61CCB2EF4233Q33372026-B98AB57C-AB93-4F8E-82FD-7EE19F5BFCB9Q33373092-99A069D9-FD04-4F08-9B16-E8AC820C10B8Q33379066-64A52380-CD3B-477C-8E2B-12614EFE5EBBQ33380732-7CF7D7A8-DB9E-45B3-845C-B3D4E659022AQ33380751-8A3EF9C8-3B27-4124-813E-D93C328FB605Q33380897-1180D848-9850-4D05-BC99-56555A2435FDQ33381700-312F0D3C-02BF-4C5F-942F-BF526F02FB84Q33389001-161464B3-082C-4519-A4B9-22EFA07860AFQ33391541-7AFD9E3E-FC82-4850-B189-C5490BE4E805Q33396931-BE0EDBDF-E292-4174-941E-1A10A20FDE86Q33397133-3A3A5513-0FA6-46A6-849D-4FCD7861A7DBQ33398405-F4448C34-71EF-46D8-B43A-8BE2C0864E51Q33399983-F135992D-9559-4DDC-90C9-2ED835E574C7Q33401605-607365F8-E15B-475D-B6B7-61958504A48FQ33402387-34AE59B4-A3F6-4D41-BA40-518CBEB405B2Q33402600-97E35824-69B1-444D-A634-BB442A180738Q33403179-ED60DD0F-E042-4D4F-8A4A-A77B91C9CD67Q33404073-CF1BBA66-8E2E-4595-BE60-7D25E70927F6Q33404097-96EB9C17-5851-473D-BF85-B652379BAEFBQ33410356-EF9156A7-348E-4ABF-A3FA-FAC790FE0B9CQ33410716-81896DFC-2ECA-4F13-B5F7-9927FC6C74B6Q33412475-5B228969-90E0-4A76-8CCA-6D441D1579A5Q33415432-9C6215CE-01DD-4E07-B57E-40E7E770A3AFQ33418251-DF75188F-06E9-4FBE-94E8-13F2B53C1134Q33420128-783D3B97-65F4-4724-AA42-E4E6C31F565EQ33420243-F0F2C418-098B-46D5-984C-F8B2CAD30DCBQ33421049-AAA527BD-3417-4CAA-8D3C-BDAAB2CB646DQ33428115-ABE8BDA4-519F-4A0A-A95B-F8F1A351D1F5Q33429368-E2D64AD5-0188-4F22-A6B4-64F29BFA71D8Q33430385-D239659F-7A9D-4FF5-808F-223B73FBF137Q33430486-F8A216FD-2A58-4B5A-83CC-3D885AD0C5EFQ33432482-40A99FF4-66C0-4000-A711-79BBB032BAE9Q33432631-220BB036-CB7A-4DB1-9DF3-0B674BC26B41
P2860
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
A prospective comparative stud ...... tal Childhood ITP Study Group.
@ast
A prospective comparative stud ...... tal Childhood ITP Study Group.
@en
type
label
A prospective comparative stud ...... tal Childhood ITP Study Group.
@ast
A prospective comparative stud ...... tal Childhood ITP Study Group.
@en
prefLabel
A prospective comparative stud ...... tal Childhood ITP Study Group.
@ast
A prospective comparative stud ...... tal Childhood ITP Study Group.
@en
P2093
P1476
A prospective comparative stud ...... tal Childhood ITP Study Group.
@en
P2093
George R Buchanan
Intercontinental Childhood ITP Study Group
Lisa A Michaels
Paul Imbach
Regina Kohan
Sherri Zimmerman
Thomas Kühne
Willi Berchtold
P304
P356
10.1067/S0022-3476(03)00535-3
P407
P577
2003-11-01T00:00:00Z